Pharmaceutical firms present in Poland are pressing on the Health Ministry to lower cost of drug registration in the country.

The office that deals with registration had income of PLN 200 million in 2013, while the cost of its functioning was at a mere PLN 47.6 million, pharmaceutical firms said.

To show the scale of pathology tied to registrations, daily Puls Biznesu gives an example of a small pharmaceutical firm that had to pay an equivalent of the price of Lexus IS 250 just to change its address in registration papers.

Registration fees in Poland are up to five times higher than in other countries with similar GDP per capita, an industry lobby said.